New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.

Publication

Citation
Manfroni G, Manvar D, Barreca ML, Kaushik-Basu N, Leyssen P, Paeshuyse J, Cannalire R, Iraci N, Basu A, Chudaev M, Zamperini C, Dreassi E, Sabatini S, Tabarrini O, Neyts J, Cecchetti V.: New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors. J Med Chem, Volume 57 (8), 2014
Authors
Barreca ML, Basu A, Cannalire R, Cecchetti V., Chudaev M, Dreassi E, Iraci N, Kaushik-Basu N, Leyssen P, Manfroni G, Manvar D, Neyts J, Paeshuyse J, Sabatini S, Tabarrini O, Zamperini C
Journal
J Med Chem
Year
2014
PubMed
24654886
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc
New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors. | MolMeDB